Myconostica
Manchester
About Myconostica
Myconostica develops and supplies molecular diagnostic products to aid rapid and accurate diagnosis of life-threatening invasive fungal infections. Traditional methods for the detection of fungal pathogens, such as culture and microscopy, are well-documented as being relatively insensitive and slow. Myconostica uses advances in molecular techniques, such as Real-Time PCR, to develop a range of assays for the rapid, accurate and sensitive detection of fungi such as Aspergillus spp., Pneumocystis jirovecii and Candida spp.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: myconostica.co.uk
- Phone: +44 (0)161 998 7239
Canonical: https://fsome.com/organization/myconostica-3160479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.